CDMO-Sourced (API & Finished Dose) Market Analysis

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Significant API volume for generic antibiotics originates from CDMO facilities in India and China, regulated by CDSCO and NMPA respectively, then finished at European or U.S. sites to meet ICH Q1-Q14 stability and quality requirements. Geopolitical concentration risk in this supply chain, particularly for penicillin and cephalosporin API, has attracted regulatory attention from FDA CDER and EMA.